NFKB1 and colorectal carcinoma: Our results suggested that aspirin, as a sensitizer, reversed the chemoresistance of CRC cells to 5-Fu and enhanced the antitumor effects of 5-Fu both in vivo and in vitro, without inducing additional toxicity, and such effects were achieved by abolishing the 5-Fu-induced NF-κB activation.